Sarcopenia em pacientes com Psoríase atendidos em Centro de referência em Psoríase do Nordeste do Brasil

Abstract

VILARINHO, Letícia Vieira da Rocha. Monograph (Bachelor). Prevalence of sarcopenia in patients with Psoriasis treated at the reference service of Hospital Universitário Lauro Wanderley. Monograph (Bachelor) - Medical Sciences Center, Federal University of Paraíba, João Pessoa, 2021. Introduction. Psoriasis is a chronic, immune-mediated disease associated with different multisystemic comorbidities. Added to this picture are new emerging diseases that seem to share inflammatory pathways and risk factors with psoriasis. There is a mutual correlation between metabolic syndrome (MS) with psoriasis and sarcopenia, thus, the possibility of sarcopenia as a comorbidity in psoriatic patients is raised. Objective. To evaluate the presence of sarcopenia in patients with psoriasis who may or may not have a diagnosis of metabolic syndrome seen at the Reference Center for Psoriasis in the State of Paraiba. Limitations: There is no way to establish a direct causal relationship between the variables, and it is impossible to ensure that the confounding factors are evenly distributed between the groups. Methodology. Cross-sectional, descriptive study involving patients with psoriasis being followed up at the Reference Center for Research, Support and Treatment of Psoriasis in the State of Paraiba, from August 2019 to February 2021. Results and discussion. The prevalence of sarcopenia in the general sample was 47.5%, being higher in the population over 46 years old. Among men, screening was positive in 54.05%, and in women, 41.86%. Of the total sample, 35% have psoriasis with MS and 65% without MS. In the first group, the frequency of sarcopenia was 39.28%, being lower than that of the group without metabolic syndrome (51.92%). Conclusion. The presence of sarcopenia was greater than that of the general population, predominating in the group without MS and in men. The importance of epidemiological information to emphasize Sarcopenia as emerging comorbidities in the care of patients with psoriasis is emphasized.